Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Torrent Pharmaceuticals

BSE: 500420|NSE: TORNTPHARM|ISIN: INE685A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 23, 16:00
1681.70
12.6 (0.75%)
VOLUME 3,690
LIVE
NSE
Oct 23, 15:59
1680.25
10.25 (0.61%)
VOLUME 241,823
Announcements on Torrent Pharma

23rd-Oct-2019 17:11Source: BSE

Torrent Pharmaceuticals- Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, ('Listing Regulations')

We would like to inform that the Board has at its meeting held today approved, inter-alia, the Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial...

18th-Oct-2019 19:00Source: BSE

Torrent Pharmaceuticals- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

In furtherance to our letter dated 16-Oct-19 on the captioned subject, we would like to inform that the teleconference with Investors / Analyst has been rescheduled to 06:00 P.M. from 06:30 P.M on 23r...

17th-Oct-2019 16:25Source: BSE

Torrent Pharmaceuticals- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Loss of Share Certificate

17th-Oct-2019 10:28Source: BSE

Torrent Pharmaceuticals- Shareholding for the Period Ended September 30, 2019

Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here

16th-Oct-2019 13:40Source: NSE

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

9th-Oct-2019 19:12Source: BSE

Torrent Pharmaceuticals- Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor compl...

9th-Oct-2019 18:19Source: BSE

Torrent Pharmaceuticals- Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

This is to inform that the Company has today received a warning letter dated 08-Oct-19 from the USFDA for its Indrad facility in Gujarat. This action follows the earlier intimation received from USFDA...

5th-Oct-2019 12:56Source: BSE

Torrent Pharmaceuticals- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 04, 2019 fo...

4th-Oct-2019 18:47Source: BSE

Torrent Pharmaceuticals- Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for half year ended...

23rd-Sep-2019 18:12Source: BSE

Torrent Pharmaceuticals- Redemption Of Commercial Paper

Pursuant to Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Commercial Paper of Rs. 100 Crores...

1 2 3 4 5 Next >>
Quick Links for Torrent Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.